Nanjing Pharmaceutical Group Company Limited (SHA:600713)

SHA:600713 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,081	6,494	6,342	6,709	5,114	4,635
Market Cap Growth	10.83%	2.41%	-5.47%	31.18%	10.34%	-4.92%
Enterprise Value	18,808	17,415	18,818	16,766	14,628	11,389
Last Close Price	5.41	4.80	4.51	4.65	4.35	3.86
PE Ratio	14.32	11.38	10.98	11.26	10.12	12.31
Forward PE	-	27.42	27.42	27.42	27.42	27.42
PS Ratio	0.13	0.12	0.12	0.13	0.11	0.12
PB Ratio	0.89	0.83	0.87	1.00	0.98	0.96
P/TBV Ratio	1.06	0.99	1.03	1.18	1.20	1.19
P/FCF Ratio	-	4.08	3.63	-	13.15	-
P/OCF Ratio	133.96	3.04	3.33	-	7.36	-
EV/Sales Ratio	0.35	0.32	0.35	0.33	0.32	0.29
EV/EBITDA Ratio	11.46	10.41	11.38	10.87	10.10	9.79
EV/EBIT Ratio	13.41	11.33	12.55	12.07	11.25	11.09
EV/FCF Ratio	-98.73	10.95	10.76	-	37.63	-
Debt / Equity Ratio	1.60	1.31	1.26	1.83	1.89	1.80
Debt / EBITDA Ratio	7.76	5.70	5.15	7.41	6.40	7.46
Debt / FCF Ratio	-	6.41	5.21	-	25.38	-
Asset Turnover	1.62	1.82	1.79	1.75	1.83	1.76
Inventory Turnover	8.01	8.33	8.68	9.12	9.83	9.58
Quick Ratio	1.08	1.16	1.00	0.97	0.99	0.92
Current Ratio	1.45	1.63	1.40	1.31	1.34	1.23
Return on Equity (ROE)	9.15%	9.88%	10.22%	12.00%	12.15%	10.06%
Return on Assets (ROA)	2.63%	3.25%	3.12%	3.02%	3.30%	2.83%
Return on Invested Capital (ROIC)	5.69%	8.31%	7.15%	7.42%	7.57%	6.34%
Return on Capital Employed (ROCE)	11.10%	11.30%	15.20%	14.80%	15.60%	16.60%
Earnings Yield	7.49%	8.79%	9.11%	8.88%	9.88%	8.12%
FCF Yield	-2.69%	24.50%	27.57%	-12.48%	7.60%	-30.19%
Dividend Yield	3.07%	3.54%	3.55%	3.01%	2.76%	2.85%
Payout Ratio	45.00%	88.47%	101.75%	81.07%	185.06%	93.72%
Buyback Yield / Dilution	-7.89%	-0.33%	-3.54%	-20.39%	0.10%	-0.09%
Total Shareholder Return	-4.82%	3.21%	0.00%	-17.39%	2.86%	2.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.